Date: 2011-11-30
Type of information: Services contract
Compound: new candidate vaccine against bovine neosporosis
Company: VitamFero (France) Oniris (France)
Therapeutic area: Veterinary medicine
Type agreement: services
Action mechanism:
Disease: bovine neosporosis
Details: VitamFero and Oniris have concluded a service agreement to study the effectiveness of a candidate vaccine against bovine neosporosis within the Centre for Research and Preclinical Investigation (CRIP) of Oniris, higher education establishment involved in a wide range of issues including animal health and public health, clinical and biomedical fields, health biotechnologies, food science and processing technology. VitamFero\'s vaccine candidate has already demonstrated its effectiveness in early trials in mice, and the company will now use a sheep model with Oniris and CRIP to test its effectiveness in preventing abortions associated with neosporosis.
Financial terms:
Latest news:
